相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy
Shuang Chen et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2022)
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
Ioline D. Henter et al.
CNS DRUGS (2021)
Regulation of NMDA glutamate receptor functions by the GluN2 subunits
Marta Vieira et al.
JOURNAL OF NEUROCHEMISTRY (2020)
Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis
Rohitesh Gupta et al.
BRITISH JOURNAL OF CANCER (2020)
Tripartite signalling by NMDA receptors
Vishaal Rajani et al.
MOLECULAR BRAIN (2020)
Radiprodil, a NR2B negative allosteric modulator, from bench to bedside in infantile spasm syndrome
Stephane Auvin et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
A comprehensive description of GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists
Wenwu Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Structural Basis of Functional Transitions in Mammalian NMDA Receptors
Tsung-Han Chou et al.
CELL (2020)
Brain NMDA Receptors in Schizophrenia and Depression
Albert Adell
BIOMOLECULES (2020)
Buclizine crystal forms: First Structural Determinations, counter-ion stoichiometry, hydration, and physicochemical properties of pharmaceutical relevance
Monalisa Bitencourt et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Dissecting diverse functions of NMDA receptors by structural biology
Jue Xiang Wang et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2019)
The Role of NMDA Receptors in Alzheimer's Disease
Jinping Liu et al.
FRONTIERS IN NEUROSCIENCE (2019)
Antipsychotic agent pimozide promotes reversible proliferative suppression by inducing cellular quiescence in liver cancer
Jia-Jie Chen et al.
ONCOLOGY REPORTS (2019)
Psychiatric Presentation of Anti-NMDA Receptor Encephalitis
Dominique Endres et al.
FRONTIERS IN NEUROLOGY (2019)
Exploring the overlapping binding sites of ifenprodil and EVT-101 in GluN2B-containing NMDA receptors using novel chicken embryo forebrain cultures and molecular modeling
Marthe F. Fjelldal et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2019)
NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update
Daniela Cadinu et al.
NEUROPHARMACOLOGY (2018)
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Targeting NMDA receptors in stroke: new hope in neuroprotection
Qiu Jing Wu et al.
MOLECULAR BRAIN (2018)
Neurotrophic, Cytoprotective, and Anti-inflammatory Effects of St. John's Wort Extract on Differentiated Mouse Hippocampal HT-22 Neurons
Gabriel A. Bonaterra et al.
FRONTIERS IN PHARMACOLOGY (2018)
Structure, function, and allosteric modulation of NMDA receptors
Kasper B. Hansen et al.
JOURNAL OF GENERAL PHYSIOLOGY (2018)
Ginsenoside Rg3 exerts anti-depressive effect on an NMDA-treated cell model and a chronic mild stress animal model
Hualin Zhang et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Rolapitant: An NK-1 Receptor Antagonist for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Bernardo L. Rapoport
REVIEWS ON RECENT CLINICAL TRIALS (2017)
Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer
Chinthalapally V. Rao et al.
CANCER RESEARCH (2016)
Allosteric modulators of NMDA receptors: multiple sites and mechanisms
Shujia Zhu et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
James A. Maier et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
iLOGP: A Simple, Robust, and Efficient Description of n-Octanol/Water Partition Coefficient for Drug Design Using the GB/SA Approach
Antoine Daina et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Crystal structure of a heterotetrameric NMDA receptor ion channel
Erkan Karakas et al.
SCIENCE (2014)
Structure, Function, and Pharmacology of NMDA Receptor Channels
V. Vyklicky et al.
PHYSIOLOGICAL RESEARCH (2014)
PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data
Daniel R. Roe et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2013)
The effect of non-competitive NMDA receptor antagonist MK-801 on neuronal activity in rodent prefrontal cortex: an animal model for cognitive symptoms of schizophrenia
Kevin Blot et al.
JOURNAL OF PHYSIOLOGY-PARIS (2013)
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Pierre Paoletti et al.
NATURE REVIEWS NEUROSCIENCE (2013)
MMPBSA.py: An Efficient Program for End-State Free Energy Calculations
Bill R. Miller et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
Differentiation of HT22 neurons induces expression of NMDA receptor that mediates homocysteine cytotoxicity
Zhongyan Zhao et al.
NEUROLOGICAL RESEARCH (2012)
Sertindole restores attentional performance and suppresses glutamate release induced by the NMDA receptor antagonist CPP
Mirjana Carli et al.
PSYCHOPHARMACOLOGY (2011)
Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations
Andrea G. Ludolph et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
HT22 hippocampal neuronal cell line possesses functional cholinergic properties
Jun Liu et al.
LIFE SCIENCES (2009)
GluN2B subunit-containing NMDA receptor antagonists prevent Aβ-mediated synaptic plasticity disruption in vivo
Neng-Wei Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Memantine:: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutarnatergic system -: too little activation is bad, too much is even worse
Chris G. Parsons et al.
NEUROPHARMACOLOGY (2007)
NMDA receptor subunits: function and pharmacology
Pierre Paoletti et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia
Marina Cuchel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Haloperidol induces neurotoxicity by the NMDA receptor downstream signaling pathway, alternative from glutamate excitotoxicity
E. Zhuravliova et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Talniflumate increases survival in a cystic fibrosis mouse model of distal intestinal obstructive syndrome
NM Walker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Ziprasidone - A review of its use in schizophrenia and schizoaffective disorder
Tracy Swainston Harrison et al.
CNS DRUGS (2006)
Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate:: role of 5-HT1A receptors
RW Invernizzi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions
M Jansen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Pharmacokinetics, metabolism and excretion of the glycine antagonist GV150526A in rat and dog
M Kajbaf et al.
XENOBIOTICA (2003)
Therapy for chronic obstructive pulmonary disease in the 21st century
LE Donnelly et al.
DRUGS (2003)
Ziprasidone: An atypical antipsychotic drug for the treatment of schizophrenia
GL Stimmel et al.
CLINICAL THERAPEUTICS (2002)
Early clinical experience with the novel NMDA receptor antagonist CNS 5161
MR Walters et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats
JA McRoberts et al.
GASTROENTEROLOGY (2001)
Receptor binding characteristics of the novel NMDA receptor glycine site antagonist [3H]GV150526A in rat cerebral cortical membranes
M Mugnaini et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)